Regulatory Perspective on Endpoint Development: How is the Regulatory Landscape Evolving with Advances in Research?

Time: 9:30 am
day: Day One


  • Establishing a clinical pathway to correlate promising biomarkers with clinical outcome
  • Advancing understanding of efficacy with the endpoints we already have
  • Evaluating the regulatory landscape for paediatric and ultra-rare clinical studies and driving diversity in clinical trials